Works matching IS 08991987 AND DT 2024 AND VI 63 AND IP 6
Results: 15
Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1188, doi. 10.1002/mc.23718
- By:
- Publication type:
- Article
The RNA‐binding protein sorbin and SH3 domain‐containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1174, doi. 10.1002/mc.23717
- By:
- Publication type:
- Article
Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1160, doi. 10.1002/mc.23716
- By:
- Publication type:
- Article
BATF promotes extramedullary infiltration through TGF‐β1/Smad/MMPs axis in acute myeloid leukemia.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1146, doi. 10.1002/mc.23715
- By:
- Publication type:
- Article
Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1133, doi. 10.1002/mc.23714
- By:
- Publication type:
- Article
The small nucleolar RNA SNORA51 enhances breast cancer stem cell‐like properties via the RPL3/NPM1/c‐MYC pathway.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1117, doi. 10.1002/mc.23713
- By:
- Publication type:
- Article
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1106, doi. 10.1002/mc.23712
- By:
- Publication type:
- Article
Effect of CHRDL1 on angiogenesis and metastasis of colorectal cancer cells via TGF‐β/VEGF pathway.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1092, doi. 10.1002/mc.23711
- By:
- Publication type:
- Article
ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1079, doi. 10.1002/mc.23710
- By:
- Publication type:
- Article
Alternative splicing‐related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR‐199a‐5p/SRSF1 axis and impacting Anillin.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1064, doi. 10.1002/mc.23709
- By:
- Publication type:
- Article
Ligand‐gated ion channels as potential biomarkers for ADT‐mediated cognitive decline in prostate cancer patients.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1051, doi. 10.1002/mc.23708
- By:
- Publication type:
- Article
JD‐02, a novel Hsp90 inhibitor, induces ROS/SRC axis‐dependent cytoprotective autophagy in colorectal cancer cells.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1038, doi. 10.1002/mc.23706
- By:
- Publication type:
- Article
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1024, doi. 10.1002/mc.23705
- By:
- Publication type:
- Article
Systematical identification of key genes and regulatory genetic variants associated with prognosis of esophageal squamous cell carcinoma.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1013, doi. 10.1002/mc.23704
- By:
- Publication type:
- Article
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 6, p. 1009, doi. 10.1002/mc.23575
- Publication type:
- Article